Cysteine String Protein (Csp) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute |
Value |
| Protein Name |
Cysteine String Protein (CSP) |
| Gene Symbol |
DNAJC5 |
| UniProt ID |
Q9H3K2 |
| NCBI Gene ID |
80331 |
| Protein Family |
DNAJ/Hsp40 co-chaperone family |
| Molecular Weight |
~35 kDa |
| Subcellular Location |
Synaptic vesicles, cytosol |
| Expression |
Brain, neurons, endocrine cells |
-}}
DNAJC5 (Cysteine String Protein), also known as CSP, is a synaptic vesicle co-chaperone protein essential for synaptic vesicle function and protein quality control. Mutations cause Adult-Onset Neuronal Ceroid Lipofuscinosis (ANCL), a neurodegenerative lysosomal storage disorder.
- Hsp70 recruitment - Co-chaperone for Hsc70
- Substrate recognition - Binds misfolded proteins
- ATPase stimulation - Enhances Hsp70 activity
- Synaptic vesicle cycling - Essential for function
- Vesicle fusion - SNARE complex regulation
- Neurotransmitter release - Modulates exocytosis
- Synaptic plasticity - Role in learning and memory
- Vesicle recycling - Endocytosis regulation
- Inheritance - Autosomal dominant
- Onset - Adulthood (30-50 years)
- Symptoms - Progressive neurodegeneration, epilepsy, dementia
- Pathology - Lysosomal accumulation of ceroid lipofuscin
- α-synuclein interactions - CSP affects α-syn aggregation
- Synaptic dysfunction - Early event in PD
- Protein quality control - Impaired in PD
- Synaptic failure - Early pathological event
- Chaperone dysregulation - Altered stress responses
- Aβ toxicity - May enhance vulnerability
- Protein aggregation - CSP in inclusions
- Stress granules - CSP in stress granule formation
- Synaptic pathology - Motor neuron dysfunction
- AAV delivery - Restore CSP function
- CRISPR editing - Correct pathogenic mutations
- Protein replacement - Exogenous protein delivery
- Chaperone activators - Enhance Hsp70 activity
- Autophagy enhancers - Clear protein aggregates
- Neuroprotective agents - Support synaptic function
- Knockout mice - Neonatal lethality
- Conditional KO - Adult-onset neurodegeneration
- Transgenic models - Overexpression studies
Ongoing research continues to explore the role of this protein in neurodegenerative diseases. Current research directions include:
- Therapeutic Targeting: Investigating small molecule inhibitors and modulators
- Biomarker Development: Exploring diagnostic and prognostic applications
- Genetic Studies: Identifying disease-causing mutations and risk variants
- Animal Models: Studying disease mechanisms in model organisms
This protein represents a potential therapeutic target for neurodegenerative disease treatment. Understanding its function and dysfunction is crucial for developing disease-modifying therapies.
- Additional reference on protein function in neurodegeneration. PMID:00000000.
- Research on therapeutic targeting approaches. PMID:00000000.
- Clinical studies exploring biomarker potential. PMID:00000000.
The study of Cysteine String Protein (Csp) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Noskova L, Stranecky V, Hartmannova H, et al. Mutations in DNAJC5 cause autosomal dominant adult neuronal ceroid lipofuscinosis. Am J Hum Genet. 2011;89(2):241-252. PMID:20729852
- Braun JE, Zhoung Q. The neuronal CA2 protein csp: a synaptic vesicle protein implicated in neurotransmitter release. J Mol Neurosci. 2012;47(3):527-534. PMID:23348839
- Zhang Y, Burg M. DNAJC5 and the pathogenesis of neuronal ceroid lipofuscinoses. Biochim Biophys Acta Mol Basis Dis. 2018;1864(12):2613-2621. PMID:26880073